摘要
目的 总结肝门部胆管癌诊断和治疗的经验。方法 回顾性分析经手术和病理证实的肝门部胆管癌 2 3例的临床特征、手术方法和随访结果。结果 2 3例中手术切除率为 39 1% (9/ 2 3) ,根治切除率为13 0 % (3/ 2 3) ,术后并发症发生率为 30 4 % (7/ 2 3) ,随访率为 6 9 6 % (16 / 2 3)。根治性切除 1、3、5年生存率分别为 10 0 % (3/ 3)、33 3% (1/ 3)、0 (0 / 3)。姑息性切除 1、1 5、2年生存率分别为 75 % (3/ 4 )、2 5 % (1/ 4 )、0(0 / 4 )。非切除者平均生存 15个月。结论 治疗应力争行根治性切除 ,对不能切除者尽量行姑息性引流及支持治疗 ,以延长生存期及提高生存质量。
Objective To explore the experience of diagnose and therapy for hepatic portal cholangiocarcinoma.Methods The clinical features and operative methods and following up results in 23 cases admitted from Jan. 1991 to Sep. 2001 were analyzed retrospectively.Results Twenty three patients underwent surgical therapy(9 resections and 14 palliative treatment).The overall resectability rate were 39.1%(9/23).The radical resectability rate was 13.0%(3/23).The postoperative complications was found in 7 cases(30.4%).Sixteen cases were followed up(69.6%).Survival rates for 1,3,5 year were 100%(3/3),33.3%(1/3) and 0(0/3),respectively in radical group and survival rates for 1,1.5,2 years were 75%(3/4),25%(1/4),0(0/4) in palliative group.The avarage survival period was 15 months in patients without surgical treatment.Conclusion Hepatic protal cholangiocarcinoma should be treated with radical resection if possible.If the tumor could not be resected,select drainage and support treatment should be chosed in order to prolong survival times and improve life quality.
出处
《中国基层医药》
CAS
2003年第4期311-312,共2页
Chinese Journal of Primary Medicine and Pharmacy
